DMM and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.

Supporting communities at The Company of Biologists

Throughout all fields of biology there are vibrant, active and engaged communities. We’re proud to host, alongside our journals, three dedicated community sites to extend our support to biologists everywhere. Find out more about the Node, preLights and FocalPlane.

Editor’s Choice - Biomimetic device and foreign body reaction cooperate for efficient tumour cell capture in murine advanced ovarian cancer

Miguel Abal and colleagues implanted a biomimetic device to recapitulate the peritoneal metastatic niche and to efficiently capture disseminating ovarian cancer cells in vivo. 

Interviews – Alec, Sara, Dimitrije, Amélie and Malabika

DMM first authors Alec Nickolls, Sara Ibrahim, Dimitrije Stanković, Amélie Bacle and Malabika Chakrabarti all share the stories behind their latest research.

Understanding the impact of fibroblast heterogeneity on skin fibrosis

In their new Review, Michael Longaker and colleagues discuss the complex aspects of fibroblast heterogeneity and the different roles of fibroblast subpopulations to help overcome skin scarring and fibrosis.